Leveraging biobank resources successfully as a commercial enterprise is a complex and challenging undertaking. In this exclusive interview Heli Salimen-Mankonen, Research Director, Auria Biobank, speaks to Andrea Charles from Pharma IQ, about driving sustainability in biobanking.
Pharma IQ: What does sustainability in biobanking mean to you?
H Salimen-Mankonen: The ageing population in Finland as well as globally is resulting in an increased health care expenditure for people i...
To continue reading this story Click Here
Upcoming Events
DigIT Pharma AI Commercial Excellence & Health 2025
September 1 - 3 2025
Palace Hotel Berlin, Germany
Register Now |
View Agenda |
Learn More
GenAI Life Science & Health 2025
September 1 - 3 2025
Berlin, Germany
Register Now |
View Agenda |
Learn More